A Trial of TAS-114 in Combination With S-1
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Taiho Oncology, Inc.
National Health Research Institutes, Taiwan
Fujian Cancer Hospital
Gilead Sciences
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Institut du Cancer de Montpellier - Val d'Aurelle
Shanghai Zhongshan Hospital
Eli Lilly and Company
Kansai Hepatobiliary Oncology Group
Zhejiang Cancer Hospital
Taiho Pharmaceutical Co., Ltd.
Disphar International B.V.
Hallym University Medical Center
National Health Research Institutes, Taiwan
Pfizer
ChineseAMS
Zhejiang Cancer Hospital
Zhejiang Cancer Hospital
AstraZeneca
Sanofi
National Cancer Center, Korea